Do we know how many of our MUR recommendations are followed?

摘要

Many changes in the NHS are not the outcome of properly evaluated studies and the medicines use review service was no exception. Several people have expressed doubts on the value of this service, claiming that there is little evidence to support its effectiveness and value for money. There has also been criticism that GPs ignore pharmacists' MUR recommendations and the All-Party Pharmacy Group has identified the need for better professional relationships between community pharmacists and GPs, which is also acknowledged in the English pharmacy White Paper. This led me to wonder if my MUR efforts have been worthwhile.